These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9369940)

  • 1. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
    Masunaga S; Ono K; Hori H; Shibata T; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
    Jpn J Cancer Res; 1997 Sep; 88(9):907-14. PubMed ID: 9369940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Suzuki M; Kinashi Y; Takagaki M; Hori H; Kasai S; Nagasawa H; Uto Y
    Jpn J Cancer Res; 2000 May; 91(5):566-72. PubMed ID: 10835503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S; Ono K; Akaboshi M; Takagaki M; Kinashi Y; Suzuki M; Abe M
    Radiat Med; 1997; 15(1):37-43. PubMed ID: 9134583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
    Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Suzuki M; Nishimura Y; Kinashi Y; Takagaki M; Hori H; Nagasawa H; Uto Y; Tsuchiya I; Sadahiro S; Murayama C
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1063-72. PubMed ID: 11429234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the sensitivity of intratumor cells during fractionated tirapazamine administration.
    Masunaga S; Ono K; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
    Jpn J Cancer Res; 2000 Jul; 91(7):731-6. PubMed ID: 10920281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Br J Radiol; 2000 Sep; 73(873):978-86. PubMed ID: 11064652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
    Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Suzuki M
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):828-39. PubMed ID: 11697329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.
    Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Suzuki M; Kinashi Y; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1163-70. PubMed ID: 9719128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An attempt to enhance chemosensitivity of quiescent cell populations in solid tumors by combined treatment with nicotinamide and carbogen.
    Masunaga S; Ono K; Akaboshi M; Kawai K; Akuta K; Takagaki M; Suzuki M; Kinashi Y; Abe M
    J Cancer Res Clin Oncol; 1996; 122(9):533-40. PubMed ID: 8781567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of combination with tirapazamine in boron neutron capture therapy.
    Masunaga S; Ono K; Sakurai Y; Hori H; Kobayashi T; Takagaki M; Suzuki M; Kinashi Y; Akaboshi M
    Jpn J Cancer Res; 1998 Jul; 89(7):768-74. PubMed ID: 9738984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
    Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
    Masunaga S; Ono K; Suzuki M; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):609-14. PubMed ID: 10541967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
    Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):391-8. PubMed ID: 10760435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
    Masunaga S; Sakurai Y; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Nagasawa H; Uto Y; Hori H; Ono K
    Br J Radiol; 2006 Dec; 79(948):991-8. PubMed ID: 16916808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells.
    Masunaga S; Ono K; Hori H; Kinashi Y; Suzuki M; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Int J Hyperthermia; 1999; 15(1):7-16. PubMed ID: 10193753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiobiologic significance of apoptosis and micronucleation in quiescent cells within solid tumors following gamma-ray irradiation.
    Masunaga S; Ono K; Suzuki M; Kinashi Y; Takagaki M
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1361-8. PubMed ID: 11286844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.